A Study to Evaluate the Safety, PK and PD of VIS171 in Participants (Healthy and With Autoimmune Disease)

NCT05418101 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Autoimmune Diseases

Interventions

DRUG: VIS171
DRUG: Placebo

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.